Journal article

Seasonality of cardiovascular risk factors: an analysis including over 230 000 participants in 15 countries

Helena Marti-Soler, Cedric Gubelmann, Stefanie Aeschbacher, Luis Alves, Martin Bobak, Vanina Bongard, Els Clays, Giovanni de Gaetano, Augusto Di Castelnuovo, Roberto Elosua, Jean Ferrieres, Idris Guessous, Jannicke Igland, Torben Jorgensen, Yuri Nikitin, Mark G O'Doherty, Luigi Palmieri, Rafel Ramos, Judith Simons, Gerhard Sulo Show all

HEART | BMJ PUBLISHING GROUP | Published : 2014

Grants

Awarded by Federal Office for Scientific, Technical, and Cultural Affairs


Awarded by Swiss National Science Foundation


Awarded by Fundacao para a Ciencia e a Tecnologia, Portugal


Awarded by Wellcome Trust


Awarded by National Institute on Aging


Awarded by Australian National Health and Medical Research Council


Awarded by Italian Ministry of University and Research (MIUR, Rome, Italy)-Programma Triennale di Ricerca


Awarded by Spanish Health Research Fund


Awarded by Agency for Management of University and Research Grants


Awarded by Spain's Ministry of Science and Innovation through the Carlos III Health Institute & European Regional Development Funds (ERDF)


Awarded by Medical Research Council


Funding Acknowledgements

BELSTRESS was supported by grants from the Federal Office for Scientific, Technical, and Cultural Affairs (ST/02/007), the FWO-Vlaanderen, and the National Fund for Scientific Research (FNRS). The Bus Sante study is funded by the Geneva University Hospitals through the General Directorate of Health (Canton of Geneva). Idris Guessous is supported by a grant from the Swiss National Science Foundation (grant #33CM30-124087). The CoLaus/PsyCoLaus study was and is supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, Switzerland and three grants of the Swiss National Science Foundation (grants #3200B0-105993, #3200B0-118308, #33CSCO-122661 and FN 33CSC0-139468). The Copenhagen City Heart Study was mainly supported by the Danish Heart Foundation. The Dubbo Study was supported by the National Health & Medical Research Council of Australia. The Epiporto study was financed by the Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/SAU-ESA/108315/2008]. The GAPP study was supported by the Liechtenstein Government, the Swiss Heart Foundation, the Swiss Society of Hypertension, the University of Basel, the University Hospital Basel, the Hanela Foundation, Schiller AG and Novartis, Switzerland. David Conen was supported by a grant of the Swiss National Science Foundation (PP00P3_133681). The HAPIEE Project is supported by research grants from Wellcome Trust (grants #064947/Z/01/Z, #081081/Z/06/Z), MacArthur Foundation 'Health and Social Upheaval (a research network)' and National Institute on Aging (grant #1R01 AG23522). The Health2006 study was financially supported by grants from the Velux Foundation; the Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; the Aase and Ejner Danielsens Foundation; ALK-Abell A/S (Horsholm, Denmark), Timber Merchant Vilhelm Bangs Foundation, MEKOS Laboratories (Denmark) and Research Centre for Prevention and Health, the Capital Region of Denmark. The Melbourne Collaborative Cohort Study (MCCS) recruitment and ongoing maintenance is funded by Cancer Council Victoria. It is also supported by the Australian National Health and Medical Research Council (grants #209057, #251533 and #396414). The enrolment phase of the Moli-sani Project was supported by research grants from Pfizer Foundation (Rome, Italy) and the Italian Ministry of University and Research (MIUR, Rome, Italy)-Programma Triennale di Ricerca, Decreto no. 1588. MONA LISA was funded by Institut de Veille Sanitaire (InVs), Institut National de la Sante et de la Recherche Medicale (INSERM), Agence Nationale de la Recherche (ANR) and Pfizer. The Osservatorio Epidemiologico Cardiovascolare (OEC) and the Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey (OEC/HES) are part of the CUORE Project of the Istituto Superiore di Sanita, Rome; both surveys were supported partly from the Italian Ministry of Health, grants of the Centre of Disease Control, and partly from the Italian Association of Hospital Cardiologists (ANMCO). The PRIME study was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Merck, Sharpe and Dohme-Chibret Laboratory. The Belfast PRIME Study was funded by the 'HSC Research and Development Office for Northern Ireland'.REGICOR Funding: Spanish Health Research Fund [FIS 94/0539, FIS PI020471]; Agency for Management of University and Research Grants [2005SGR00577], and Spain's Ministry of Science and Innovation through the Carlos III Health Institute & European Regional Development Funds (ERDF) [HERACLES Program RD12/0042]. The Workforce Diabetes Survey was supported by research grants from the Health Research Council of New Zealand.